Systematic (IUPAC) name | |
---|---|
1-phenylbutan-2-amine | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | Uncontrolled (in certain circumstances, may be illegal under the Federal Analogue Act in the United States and under similar bills in other countries) |
Routes | Oral |
Identifiers | |
CAS number | 53309-89-0 |
ATC code | None |
PubChem | CID 103771 |
ChemSpider | 93687 |
Chemical data | |
Formula | C10H15N |
Mol. mass | 149.23 g/mol |
SMILES | eMolecules & PubChem |
Phenylisobutylamine, also known as α-ethylphenethylamine or AEPEA[1], is a stimulant drug of the phenethylamine class. It is a higher homologue of amphetamine, differing from amphetamine's molecular structure only by the substitution of the methyl group at the alpha position of the side chain with an ethyl group. Compared to amphetamine, phenylisobutylamine has strongly reduced dopaminergic effects, and instead acts as a selective norepinephrine releasing agent. The dextro isomer of phenylisobutylamine partially substitutes for dextroamphetamine in rats.[1]
A number of derivatives of phenylisobutylamine are known, including BDB, MBDB, EBDB, butylone (bk-MBDB), eutylone (bk-EBDB), Ariadne (α-Et-DOM), 4-CAB, and 4-MAB.
|
|